Formulation and evaluation of hydrophilic matrix tablets of diltiazem using factorial design based studies

Pharmazie

Volumn 54, Issue 12, 1999, Pages 910-914

  Çelebi, Nevin ^a   Unlu G ^b  

^a GAZI UNIVERSITY   (Turkey)

^b Refik Saydam Zent Inst Hyg   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM PHOSPHATE DIBASIC; DILTIAZEM; EXCIPIENT; HYDROXYPROPYLMETHYLCELLULOSE; LACTOSE; MANNITOL;

ARTICLE; DIFFUSION; HYDROPHILICITY; PH; SUSTAINED DRUG RELEASE; TABLET FORMULATION;

EID: 0344146470     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Vazquez, M. J.; Perez-Marcos, B.; Gomez-Amoza, J. L.; Martino-Pacheco, R.; Souto, C.; Concheiro, A.: Drug Dev. Ind. Pharm. 18, 1355 (1992)
2. Hashim, A.; Wanpola, L. A.: Int. J. Pharm. 35, 201 (1987)
3. Ford, J. L.; Rubinstein, M. H.; Mclaul, F.; Hogan, J. E.; Edgarp, J.: Int. J. Pharm. 40, 223 (1987)
4. Alderman, D. A.: Int. J. Pharm. Technol. Prod. Mfr. 5, 1 (1984)
5. Higuchi, W. I.: J. Pharm. Sci. 51, 802 (1962)
6. Higuchi, T.: J. Pharm. Sci. 52, 1145 (1963)
7. Khare, A. R.; Massomi, G.; Colombo, P.; Peppas, N. A.: Proceed. Intern. Symp. Control. Rel. Bioact. Mater. 18, 263 (1991)
8. Lee, P. I.: J. Control. Rel. 2, 277 (1985).
9. Korsmayer, R. W.; Gurny, R.; Doelker, E.; Buri, P.; Peppas, N. A.: Int. J. Pharm. 15, 23 (1983)
10. Kararh, T. T.; Catalono, T.: Pharm. Res. 7, 1186 (1990)
11. Dahl, T. C.; Calderwood, T.; Bormeth, A.; Trimble, K.: J. Control. Rel. 14, 1 (1990)
12. Cheong, L. W. S.; Heng, P. W. S.; Wong, L. F.: Pharm. Res. 9, 1510 (1992)
13. Ford, J. L.; Rubinstein, M. H.; Hogan, J. E.: Int. J. Pharm. 24, 327 (1985)
14. Ford, J. L.; Rubinstein, M. H.; Hogan, J. E.: Int. J. Pharm. 24, 339 (1985)
15. Ford, J. L.; Rubinstein, M. H.; Hogan, J. E.: J. Pharm. Pharmacol 37, 338 (1985)
16. Colombo, P., Cattellani, P. L.; Peppas, N. A.; Maggi, L.; Conte, U.: Int. J. Pharm. 88, 99 (1992)
17. Klein, M. O.; Weiner, O. A.: Circulation 75 (Suppl IV) V110 (1987)
18. Ünlü, G.; Çelebi, N.: Proceed. Intern. Symp. Control. Rel. Bioact. Mater. 21, 742 (1994)
19. Salsa, T.; Veiga, F.: Pina, M. E.: Drug Dev. Ind. Pharm. 23, 929 (1997)
20. Wan, L. S. C.; Heng, P. W. S.; Wong, L. F.: Drug Dev. Ind. Pharm. 19, 1201 (1993)
21. Baveja, S. K.; Rao, R. K. V.; Devi, P.: Int. J. Pharm. 56, 51 (1987)
22. Vazquez, M. J.; Casalderrey, M.; Duro, R.; Gomez-Amoza, J. L.; Martinez-Pacheco, R.; Souto, C.; Concheiro, A.: Eur. J. Pharm. Sci. 4, 35 (1996)
23. Lapidus, H.; Lordi, N. G.: J. Pharm. Sci. 57, 1292 (1968)
24. Aǧabeyoǧlu, İ. T.; XVIII semaine medicale balkaniqe, İstanbul 30 Aout. 4-Sept., Resumes, p. 327 (1984)
25. Peppas, A. N.: Pharm. Acta. Helv. 60, 110 (1985)
26. Armstrong, N.; Jamsws, K. C.: Factorial design of experiments; in: Armstrong, N. K. (ed.): Understanding experiment design and interpretation in pharmaceutics, p. 27. Ellis Harwood Limited, West Sussex, England, 1990
27. Kinney, E. V.; Maskowitz, R. M.; Zelis, R.: J. Clin. Pharmacol. 21, 337 (1981)
28. Kölle, E.; Ochs, H.; Vollmer, K. O.: Arzneim.-Forsch/Drug. Res. 33, 972 (1983)
29. Hoglund, P.; Nilsson, L. D.: Ther. Drug. Monit. 11, 558 (1989)
30. Hermann, P.; Rodger, S. D.; Remones, G.; Thenot, J. P.; London, D. R.; Morselli, P. L.: Eur. J. Clin. Pharmacol. 24, 349 (1983)